← Leaderboards
Alexander Bukreyev
University Of Texas Med Br Galveston
$20,278,136
Attributed
$25,013,874
Total exposure
17
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.8M · FY2013–25$10M$7.5M$5M$2.5M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$36,356,546 · 18
By mechanism
P01$18,200,636 · 10
U19$9,967,219 · 5
R01$8,188,691 · 3
Top collaborators
- Mariano A. Garcia-Blanco17 shared
- James E Crowe5 shared
- Jens Meiler5 shared
- Robert Koehler Abbott1 shared
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Ricardo Rajsbaum$9,241,897
- Ian Maclachlan$4,986,074
- Jens Meiler$20,483,777
- Alison Paige Adams$358,877
- Stefan L Hamm$761,773
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusEbola VirusDisease OutbreaksVaccinesInfectionVirus DiseasesMissionCellsResponseNonhuman PrimateImmune ResponseLeadViral Hemorrhagic FeversInvestigationInterferonsFilovirusGenetic TranscriptionUnited States National Institutes Of HealthProteinsPathogenBaseIn VivoImmuneDemocratic Republic Of The Congo
Grant awards (56)
Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus$2,295,613
P01 · FY2025 · AI · contact PI
Circularization of RNA to improve the durability of the vaccine immune response$798,400
R01 · FY2025 · AI
Core B: Biosafety Level 4 Core$562,319
P01 · FY2025 · AI · contact PI
Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease$428,374
P01 · FY2025 · AI · contact PI
Research Project 2: Role of Posttranscriptional Regulatory Networks in the Pathogenesis of Ebola Virus Disease$412,527
P01 · FY2025 · AI · contact PI
Core C: Proteogenomics Core$351,156
P01 · FY2025 · AI · contact PI
Research Project 3: Role of Posttranslational Protein Modifications in the Pathogenesis of Ebola Virus Disease$350,249
P01 · FY2025 · AI · contact PI
Core D: Bioinformatics and Modeling Core$125,279
P01 · FY2025 · AI · contact PI
Core A: Administrative Core$65,709
P01 · FY2025 · AI · contact PI
Nucleic acid vaccines targeting hantaviruses$2,727,988
U19 · FY2024 · AI · contact PI
Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus$2,046,958
P01 · FY2024 · AI · contact PI
Core D: Bioinformatics and Modeling Core$470,698
P01 · FY2024 · AI · contact PI
Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease$411,174
P01 · FY2024 · AI · contact PI
Research Project 2: Role of Posttranscriptional Regulatory Networks in the Pathogenesis of Ebola Virus Disease$358,578
P01 · FY2024 · AI · contact PI
Research Project 3: Role of Posttranslational Protein Modifications in the Pathogenesis of Ebola Virus Disease$351,452
P01 · FY2024 · AI · contact PI
Core B: Biosafety Level 4 Core$215,675
P01 · FY2024 · AI · contact PI
Core C: Proteogenomics Core$165,687
P01 · FY2024 · AI · contact PI
Core A: Administrative Core$73,694
P01 · FY2024 · AI · contact PI
Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus$2,213,113
P01 · FY2023 · AI · contact PI
Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus Vaccine$766,992
R01 · FY2023 · AI · contact PI
Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease$411,831
P01 · FY2023 · AI · contact PI
Core B: Biosafety Level 4 Core$215,210
P01 · FY2023 · AI · contact PI
Core A: Administrative Core$83,092
P01 · FY2023 · AI · contact PI
Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus$2,528,313
P01 · FY2022 · AI · contact PI
Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus Vaccine$756,658
R01 · FY2022 · AI · contact PI
Core A: Administrative Core$361,188
P01 · FY2022 · AI · contact PI
Core B: Biosafety Level 4 Core$361,188
P01 · FY2022 · AI · contact PI
Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease$361,187
P01 · FY2022 · AI · contact PI
Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus$2,258,675
P01 · FY2021 · AI · contact PI
Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus Vaccine$758,862
R01 · FY2021 · AI · contact PI
Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease$425,513
P01 · FY2021 · AI · contact PI
Core B: Biosafety Level 4 Core$215,591
P01 · FY2021 · AI · contact PI
Core A: Administrative Core$80,593
P01 · FY2021 · AI · contact PI
Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus Vaccine$769,175
R01 · FY2020 · AI · contact PI
Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus Vaccine$825,853
R01 · FY2019 · AI · contact PI
Project-003$551,532
U19 · FY2018 · AI · contact PI
Mechanisms of "immune paralysis" caused by filoviruses$99,590
U19 · FY2018 · AI · contact PI
Broadly Specific Needle-Free Vaccines against Emerging and Biothreat Viruses$740,494
R01 · FY2017 · AI · contact PI
Project-003$553,514
U19 · FY2017 · AI · contact PI
Mechanisms of "immune paralysis" caused by filoviruses$90,006
U19 · FY2017 · AI · contact PI
Broadly Specific Needle-Free Vaccines against Emerging and Biothreat Viruses$740,494
R01 · FY2016 · AI · contact PI
SMALL MOLECULES DISABLING DEPHOSPHORYLATION OF EBOLA AND$633,523
U19 · FY2016 · AI · contact PI
SMALL MOLECULES DISABLING DEPHOSPHORYLATION OF EBOLA AND$578,657
U19 · FY2016 · AI · contact PI
BIOSAFETY LEVEL 4 CORE$497,643
U19 · FY2016 · AI · contact PI
BIOSAFETY LEVEL 4 CORE$454,545
U19 · FY2016 · AI · contact PI
Mechanisms of "immune paralysis" caused by filoviruses$361,816
U19 · FY2016 · AI · contact PI
Mechanisms of "immune paralysis" caused by filoviruses$361,428
U19 · FY2016 · AI · contact PI
Broadly Specific Needle-Free Vaccines against Emerging and Biothreat Viruses$740,494
R01 · FY2015 · AI · contact PI
SMALL MOLECULES DISABLING DEPHOSPHORYLATION OF EBOLA AND$642,737
U19 · FY2015 · AI · contact PI
BIOSAFETY LEVEL 4 CORE$504,883
U19 · FY2015 · AI · contact PI
Mechanisms of "immune paralysis" caused by filoviruses$364,515
U19 · FY2015 · AI · contact PI
Broadly Specific Needle-Free Vaccines against Emerging and Biothreat Viruses$736,800
R01 · FY2014 · AI · contact PI
SMALL MOLECULES DISABLING DEPHOSPHORYLATION OF EBOLA AND$658,725
U19 · FY2014 · AI · contact PI
BIOSAFETY LEVEL 4 CORE$517,441
U19 · FY2014 · AI · contact PI
Mechanisms of "immune paralysis" caused by filoviruses$368,676
U19 · FY2014 · AI · contact PI
Broadly Specific Needle-Free Vaccines against Emerging and Biothreat Viruses$554,469
R01 · FY2013 · AI · contact PI